Samuel Marsh is a postdoctoral neuroimmunologist and associated personnel at Boston Children's Hospital/Broad/Harvard with eight years of experience applying single-cell genomics, proteomics, and ELISA to uncover mechanisms and biomarkers in neurodegenerative disease. He led development and validation of optimized wet-lab protocols for microglia and CSF immune cell processing—work that identified artifactual transcriptional signatures and culminated in a Nature Neuroscience methods paper. Comfortable at the bench and at the command line, he also develops open-source R tools (scCustomize) and contributed visualization improvements to the widely used Seurat package. His work uniquely spans living-patient CSF/blood cohorts and post-mortem/acute brain tissue, and he has translated those technical advances into novel biomarker assays and a discovered CSF immune cell population enriched for Alzheimer’s risk.
8 years of coding experience
3 years of employment as a software developer
Bachelor of Science (B.S.), Behavioral Neuroscience, Bachelor of Science (B.S.), Behavioral Neuroscience at Northeastern University
Doctor of Philosophy (Ph.D.), Neurobiology & Behavior, Doctor of Philosophy (Ph.D.), Neurobiology & Behavior at University of California, Irvine
Contributions:31 commits, 38 PRs, 1195 comments in 1 year 8 months
Contributions summary:Samuel primarily contributed to the `seurat` R package, focusing on enhancing the visualization capabilities for single-cell genomics data. Their contributions included adding features like "do.shuffle" to the `DimPlot` function and expanding the functionality of `FeaturePlot` by introducing parameters such as `keep.scale` and `raster`. Further, they updated and refined existing functions like `CellCycleScoring`, addressing typos and documentation for improved usability and clarity.
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.